FDA Issues Warning Letter to Neobiosis
June 19, 2024
June 19, 2024
WASHINGTON, June 19 -- The U.S. Department of Health and Human Services' Food and Drug Administration issued the following warning letter to Neobiosis LLC:
* * *
To: Ian A. White, Ph.D., President, Chief Executive Officer and Co-owner, Neobiosis, LLC, 305 SW 7th Terrace, Gainesville, FL 32601-6458, United States
Dear Dr. White:
During an inspection of your firm, Neobiosis, LLC (hereinafter, "Neobiosis"), located at 305 SW 7th Terrace, . . .
* * *
To: Ian A. White, Ph.D., President, Chief Executive Officer and Co-owner, Neobiosis, LLC, 305 SW 7th Terrace, Gainesville, FL 32601-6458, United States
Dear Dr. White:
During an inspection of your firm, Neobiosis, LLC (hereinafter, "Neobiosis"), located at 305 SW 7th Terrace, . . .